Chhoti Kateli may help prevent tuberculosis, says new Patanjali research
Patanjali researchers turned to Solanum virginianum extract (SVE) and explored whether the plant compound might provide a safer, more environmentally friendly option.
Patanjali researchers turned to Solanum virginianum extract (SVE) and explored whether the plant compound might provide a safer, more environmentally friendly option.
Patanjali’s research on Solanum virginianum extract (SVE) or ‘Chhoti Kateli’ aims to develop herbal therapies that can either stand alone or complement existing anti-TB drugs.
